| Title |
Pharmacological management of co-morbid conditions at the end of life: is less more?
|
|---|---|
| Published in |
Irish Journal of Medical Science, July 2012
|
| DOI | 10.1007/s11845-012-0841-6 |
| Pubmed ID | |
| Authors |
S. McLean, B. Sheehy-Skeffington, N. O’Leary, A. O’Gorman |
| Abstract |
Co-morbid conditions (CMCs) are present in over half of patients with cancer over 50 years of age. As life-limiting illnesses progress, the benefits and burdens of treatments for CMCs become unclear. Relevant issues include physiological changes in advanced illness, time-to-benefit of medications, burden of medications, and psychological impact of discontinuing medications. Optimal prescribing is unclear due to lack of evidence. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 90 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 13% |
| Student > Master | 12 | 13% |
| Student > Ph. D. Student | 11 | 12% |
| Other | 8 | 9% |
| Student > Postgraduate | 8 | 9% |
| Other | 21 | 23% |
| Unknown | 18 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 46% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 9% |
| Nursing and Health Professions | 7 | 8% |
| Agricultural and Biological Sciences | 2 | 2% |
| Psychology | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 23 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2012.
All research outputs
#18,313,878
of 22,675,759 outputs
Outputs from Irish Journal of Medical Science
#970
of 1,396 outputs
Outputs of similar age
#126,188
of 164,753 outputs
Outputs of similar age from Irish Journal of Medical Science
#3
of 4 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,396 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,753 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.